Bioprocessing White Papers

  1. A Molecule’s Journey – Break Down Roadblocks To Commercial Success
    1/4/2018

    A guide for today’s biopharma executives seeking to navigate through the important considerations necessary to successfully build their own cGMP biomanufacturing facility.

  2. Scalable Strategies For Parenteral Dosage Form Selection
    12/29/2017

    Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.

     

  3. Multiplexing: Managing Risk With Proven, Single-Use Solutions
    11/27/2017

    With many uncertainties when introducing a new drug to market, seeking manufacturing flexibility to accommodate diverse demands and production needs is key.

  4. Single-Use Automation: Unlock The True Potential Of Single-Use Tech
    11/9/2017

    Discover how through automation, it is possible to achieve data acquisition, process monitoring and control, and batch record generation, allowing more complex unit operations to be run in cGMP environments.

  5. A QUICK Guide To Selecting A CMO
    11/7/2017

    A thorough and systematic process to holistically gauge the attributes of a firm that are critical to creating an effective outsourcing relationship.

  6. The Race to Phase III: A Cautionary Tale of Scalability
    10/30/2017

    Follow the paths of two companies as they learn how a science-led, risk-based development approach yields a more successful outcome in the long run.

  7. Are The Components In Your Prefilled Syringes Compatible?
    10/27/2017

    While a prefilled syringe offers many advantages for biologic products, manufacturers must evaluate the potential impact of a prefilled syringe on product quality prior to selecting the final components.

  8. Successful Commercial Strategy For Advancing A Molecule From The Laboratory To The Clinic
    10/24/2017

    Experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible  without sacrificing product quality, process efficiency, or patient safety.

  9. Laying The Foundation For Viral Safety
    10/20/2017

    Mitigating the risk of viral contamination in vaccines, cell, and gene therapies.

  10. Understanding And Defining Laboratory Capacity In Biopharma
    10/19/2017

    Examine the options available for measuring your laboratory capacity.